Share Price and Basic Stock Data
Last Updated: November 15, 2025, 4:26 pm
| PEG Ratio | 1.41 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Vesuvius India Ltd operates in the refractories industry, primarily serving the steel and foundry sectors. The company reported a revenue of ₹1,603 Cr for the year ending December 2023, reflecting a significant growth from ₹1,343 Cr in December 2022. This upward trend in sales is evident in the quarterly figures, where revenues rose from ₹368 Cr in March 2023 to ₹453 Cr by March 2024. The company has demonstrated a consistent increase in sales over the years, with a remarkable compound annual growth rate (CAGR) from ₹602 Cr in December 2013 to ₹1,603 Cr in December 2023. The latest quarterly report for June 2025 indicates sales of ₹524 Cr, showing a robust performance in the first half of the fiscal year. Vesuvius India’s ability to capitalize on the growing demand for refractories in the steel sector has been a crucial driver of its revenue growth, positioning it favorably against competitors in the industry.
Profitability and Efficiency Metrics
Vesuvius India has showcased impressive profitability metrics, with a net profit of ₹213 Cr for the year ended December 2023, up from ₹117 Cr in December 2022. The gross profit margin stood at 18% in December 2023, while the operating profit margin (OPM) was reported at 18%, indicating efficient cost management. The company’s return on equity (ROE) is strong at 19.3%, and return on capital employed (ROCE) is notably high at 25.5%, reflecting effective utilization of capital. Furthermore, the interest coverage ratio (ICR) of 335.48x emphasizes Vesuvius India’s robust ability to meet its interest obligations with substantial earnings. The cash conversion cycle (CCC) of 58 days indicates efficient working capital management, contributing positively to liquidity. These profitability and efficiency metrics not only highlight the company’s operational prowess but also its capacity to generate returns for shareholders, establishing a strong foothold in the refractories market.
Balance Sheet Strength and Financial Ratios
Vesuvius India’s balance sheet reflects a solid financial position, with total assets amounting to ₹2,008 Cr as of June 2025. The company reported reserves of ₹1,502 Cr, showcasing a healthy equity base. The debt levels remain remarkably low, with borrowings recorded at just ₹14 Cr, underscoring a conservative approach to leverage. The price-to-book value (P/BV) ratio stands at 6.46x, indicating a premium valuation in the market. Furthermore, the current ratio of 3.12x and quick ratio of 2.47x demonstrate strong liquidity, allowing the company to comfortably meet short-term obligations. The net profit margin of 14.15% for December 2024 reflects effective cost control and pricing strategies. Overall, Vesuvius India’s strong balance sheet and favorable financial ratios position it well for sustained growth and resilience against economic fluctuations.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vesuvius India indicates a stable ownership structure, with promoters holding 55.57% of the equity. This substantial promoter stake reflects confidence in the company’s long-term vision. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 4.31% and 20.83%, respectively, demonstrating a solid interest from institutional players. The public shareholding stands at 19.29%, with the number of shareholders increasing to 34,163 as of June 2025, indicating growing retail investor interest. This diversified ownership base can enhance liquidity and foster market confidence. However, the relatively low FII participation highlights potential room for increased foreign investment. Overall, the shareholding dynamics suggest a positive outlook for investor sentiment, reinforcing the company’s credibility in the equity market.
Outlook, Risks, and Final Insight
Looking ahead, Vesuvius India is poised to benefit from the ongoing demand for refractories, driven by the recovery in the steel sector. However, potential risks include fluctuations in raw material prices and changes in regulatory policies impacting the industry. The company’s low debt levels provide a buffer against economic downturns, yet a high P/BV ratio may indicate vulnerability to market corrections. While the growth trajectory appears promising, maintaining operational efficiency and managing cost pressures will be crucial for sustaining profitability. The company’s ability to adapt to market dynamics and leverage its strong balance sheet will be key in navigating future challenges. In summary, Vesuvius India is well-positioned for growth, but diligent risk management will be essential to capitalize on emerging opportunities while mitigating potential downsides.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vesuvius India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Morganite Crucible (India) Ltd | 876 Cr. | 1,564 | 1,964/1,170 | 34.6 | 242 | 3.13 % | 30.4 % | 21.4 % | 5.00 |
| Associated Ceramics Ltd | 62.9 Cr. | 209 | 320/177 | 19.6 | 86.2 | 0.00 % | 10.8 % | 9.55 % | 10.0 |
| Vesuvius India Ltd | 10,009 Cr. | 493 | 647/356 | 41.1 | 75.0 | 0.29 % | 25.5 % | 19.3 % | 1.00 |
| IFGL Refractories Ltd | 1,687 Cr. | 234 | 340/163 | 56.7 | 154 | 1.50 % | 5.71 % | 3.94 % | 10.0 |
| Industry Average | 4,190.67 Cr | 625.00 | 38.00 | 139.30 | 1.23% | 18.10% | 13.55% | 6.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 330 | 353 | 348 | 368 | 405 | 413 | 417 | 453 | 462 | 444 | 509 | 482 | 524 |
| Expenses | 289 | 303 | 309 | 313 | 335 | 331 | 337 | 358 | 371 | 365 | 427 | 399 | 433 |
| Operating Profit | 41 | 50 | 40 | 55 | 70 | 82 | 80 | 95 | 92 | 79 | 82 | 83 | 91 |
| OPM % | 12% | 14% | 11% | 15% | 17% | 20% | 19% | 21% | 20% | 18% | 16% | 17% | 17% |
| Other Income | 5 | 6 | 7 | 11 | 8 | 8 | 7 | 8 | 10 | 23 | 7 | 10 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 7 | 8 | 9 | 8 | 8 | 9 | 11 | 10 | 11 | 12 | 13 | 13 | 15 |
| Profit before tax | 39 | 49 | 37 | 58 | 70 | 81 | 76 | 92 | 90 | 90 | 76 | 80 | 85 |
| Tax % | 25% | 26% | 26% | 25% | 25% | 25% | 25% | 25% | 26% | 24% | 22% | 26% | 26% |
| Net Profit | 29 | 36 | 28 | 43 | 52 | 60 | 57 | 69 | 67 | 68 | 60 | 59 | 63 |
| EPS in Rs | 1.45 | 1.78 | 1.36 | 2.14 | 2.57 | 2.97 | 2.81 | 3.39 | 3.32 | 3.37 | 2.95 | 2.92 | 3.10 |
Last Updated: August 20, 2025, 1:30 am
Below is a detailed analysis of the quarterly data for Vesuvius India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 524.00 Cr.. The value appears strong and on an upward trend. It has increased from 482.00 Cr. (Mar 2025) to 524.00 Cr., marking an increase of 42.00 Cr..
- For Expenses, as of Jun 2025, the value is 433.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 399.00 Cr. (Mar 2025) to 433.00 Cr., marking an increase of 34.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 91.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2025) to 91.00 Cr., marking an increase of 8.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00%.
- For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2025) to 85.00 Cr., marking an increase of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.10. The value appears strong and on an upward trend. It has increased from 2.92 (Mar 2025) to 3.10, marking an increase of 0.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:11 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 602 | 652 | 700 | 822 | 911 | 925 | 887 | 792 | 1,047 | 1,343 | 1,603 | 1,869 | 2,062 |
| Expenses | 489 | 552 | 574 | 670 | 745 | 777 | 766 | 714 | 947 | 1,178 | 1,314 | 1,518 | 1,714 |
| Operating Profit | 112 | 101 | 126 | 152 | 167 | 148 | 121 | 77 | 100 | 165 | 289 | 350 | 349 |
| OPM % | 19% | 15% | 18% | 18% | 18% | 16% | 14% | 10% | 10% | 12% | 18% | 19% | 17% |
| Other Income | 5 | 9 | 10 | 13 | 9 | 23 | 29 | 21 | 20 | 23 | 35 | 48 | 33 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 1 |
| Depreciation | 18 | 19 | 23 | 27 | 30 | 28 | 27 | 26 | 27 | 30 | 36 | 46 | 57 |
| Profit before tax | 99 | 90 | 112 | 136 | 145 | 142 | 123 | 72 | 92 | 157 | 285 | 349 | 323 |
| Tax % | 34% | 34% | 35% | 35% | 35% | 35% | 31% | 26% | 26% | 26% | 25% | 24% | |
| Net Profit | 65 | 59 | 74 | 89 | 94 | 93 | 86 | 53 | 68 | 117 | 213 | 265 | 244 |
| EPS in Rs | 3.21 | 2.91 | 3.63 | 4.38 | 4.65 | 4.56 | 4.21 | 2.61 | 3.35 | 5.75 | 10.49 | 13.03 | 12.00 |
| Dividend Payout % | 15% | 24% | 17% | 15% | 15% | 15% | 21% | 27% | 24% | 14% | 12% | 11% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | 21% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 24% |
| 3 Years: | 55% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 41% |
| 3 Years: | 55% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| Last Year: | 19% |
Last Updated: September 5, 2025, 1:51 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 108 | 105 | 118 | 119 | 88 | 72 | 77 | 75 | 57 | 57 | 74 | 75 |
| Inventory Days | 65 | 69 | 68 | 77 | 69 | 84 | 77 | 91 | 124 | 92 | 105 | 87 |
| Days Payable | 83 | 87 | 97 | 98 | 111 | 98 | 89 | 122 | 130 | 112 | 118 | 104 |
| Cash Conversion Cycle | 91 | 87 | 90 | 98 | 46 | 58 | 65 | 44 | 52 | 38 | 60 | 58 |
| Working Capital Days | 88 | 82 | 91 | 102 | 59 | 58 | 63 | 51 | 55 | 41 | 65 | 62 |
| ROCE % | 27% | 22% | 24% | 25% | 24% | 20% | 16% | 9% | 11% | 17% | 26% | 25% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 1,626,602 | 2.24 | 577.41 | 1,626,602 | 2025-04-22 17:25:16 | 0% |
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 736,302 | 0.44 | 261.37 | 736,302 | 2025-04-22 13:31:13 | 0% |
| Axis Small Cap Fund | 690,296 | 1.25 | 245.04 | 690,296 | 2025-04-22 17:25:16 | 0% |
| HDFC Small Cap Fund - Regular Plan | 389,784 | 0.48 | 138.37 | 389,784 | 2025-04-22 17:25:16 | 0% |
| HDFC Multi Cap Fund | 387,773 | 1.17 | 137.65 | 387,773 | 2025-04-22 17:25:16 | 0% |
| Nippon India Small Cap Fund | 288,000 | 0.22 | 102.23 | 288,000 | 2025-04-22 17:25:16 | 0% |
| Tata Small Cap Fund | 231,256 | 1.34 | 82.09 | 231,256 | 2025-04-22 17:25:16 | 0% |
| Tata Mid Cap Growth Fund - Regular Plan | 94,177 | 1.04 | 33.43 | 94,177 | 2025-04-22 17:25:16 | 0% |
| HDFC Retirement Savings Fund - Hybrid Equity - Regular Plan | 36,000 | 0.97 | 12.78 | 36,000 | 2025-04-22 17:25:16 | 0% |
| WhiteOak Capital Flexi Cap Fund | 30,890 | 0.37 | 10.97 | 30,890 | 2025-04-22 17:25:16 | 0% |
Key Financial Ratios
| Month | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 130.33 | 104.92 | 57.54 | 33.53 | 26.13 |
| Diluted EPS (Rs.) | 130.33 | 104.92 | 57.54 | 33.53 | 26.13 |
| Cash EPS (Rs.) | 152.89 | 122.59 | 72.24 | 46.99 | 39.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 704.92 | 587.95 | 491.52 | 441.53 | 414.68 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 704.92 | 587.95 | 491.52 | 441.53 | 414.68 |
| Dividend / Share (Rs.) | 14.50 | 12.75 | 8.25 | 8.00 | 7.00 |
| Revenue From Operations / Share (Rs.) | 920.48 | 789.72 | 661.37 | 515.84 | 389.91 |
| PBDIT / Share (Rs.) | 195.01 | 158.50 | 91.98 | 58.57 | 48.17 |
| PBIT / Share (Rs.) | 172.42 | 140.80 | 77.27 | 45.10 | 35.25 |
| PBT / Share (Rs.) | 171.84 | 140.59 | 77.27 | 45.10 | 35.25 |
| Net Profit / Share (Rs.) | 130.31 | 104.90 | 57.53 | 33.52 | 26.13 |
| PBDIT Margin (%) | 21.18 | 20.07 | 13.90 | 11.35 | 12.35 |
| PBIT Margin (%) | 18.73 | 17.82 | 11.68 | 8.74 | 9.03 |
| PBT Margin (%) | 18.66 | 17.80 | 11.68 | 8.74 | 9.03 |
| Net Profit Margin (%) | 14.15 | 13.28 | 8.69 | 6.49 | 6.70 |
| Return on Networth / Equity (%) | 18.48 | 17.84 | 11.70 | 7.59 | 6.30 |
| Return on Capital Employeed (%) | 23.79 | 23.22 | 15.33 | 9.95 | 8.28 |
| Return On Assets (%) | 14.32 | 13.40 | 8.77 | 5.72 | 5.01 |
| Asset Turnover Ratio (%) | 1.09 | 1.10 | 1.07 | 0.93 | 0.77 |
| Current Ratio (X) | 3.12 | 3.10 | 3.34 | 3.65 | 4.46 |
| Quick Ratio (X) | 2.47 | 2.38 | 2.67 | 2.85 | 3.86 |
| Inventory Turnover Ratio (X) | 2.59 | 2.64 | 2.45 | 2.69 | 2.80 |
| Dividend Payout Ratio (NP) (%) | 9.78 | 7.86 | 13.90 | 20.88 | 26.78 |
| Dividend Payout Ratio (CP) (%) | 8.33 | 6.72 | 11.07 | 14.89 | 17.92 |
| Earning Retention Ratio (%) | 90.22 | 92.14 | 86.10 | 79.12 | 73.22 |
| Cash Earning Retention Ratio (%) | 91.67 | 93.28 | 88.93 | 85.11 | 82.08 |
| Interest Coverage Ratio (X) | 335.48 | 748.26 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 225.17 | 496.21 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 8763.00 | 6817.43 | 2711.20 | 1644.13 | 1658.00 |
| EV / Net Operating Revenue (X) | 4.69 | 4.25 | 2.02 | 1.57 | 2.09 |
| EV / EBITDA (X) | 22.14 | 21.19 | 14.52 | 13.83 | 16.95 |
| MarketCap / Net Operating Revenue (X) | 4.95 | 4.54 | 2.44 | 2.10 | 2.80 |
| Retention Ratios (%) | 90.21 | 92.13 | 86.09 | 79.11 | 73.21 |
| Price / BV (X) | 6.46 | 6.10 | 3.29 | 2.45 | 2.63 |
| Price / Net Operating Revenue (X) | 4.95 | 4.54 | 2.44 | 2.10 | 2.80 |
| EarningsYield | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
After reviewing the key financial ratios for Vesuvius India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Dec 24, the value is 130.33. This value is within the healthy range. It has increased from 104.92 (Dec 23) to 130.33, marking an increase of 25.41.
- For Diluted EPS (Rs.), as of Dec 24, the value is 130.33. This value is within the healthy range. It has increased from 104.92 (Dec 23) to 130.33, marking an increase of 25.41.
- For Cash EPS (Rs.), as of Dec 24, the value is 152.89. This value is within the healthy range. It has increased from 122.59 (Dec 23) to 152.89, marking an increase of 30.30.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 704.92. It has increased from 587.95 (Dec 23) to 704.92, marking an increase of 116.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 704.92. It has increased from 587.95 (Dec 23) to 704.92, marking an increase of 116.97.
- For Dividend / Share (Rs.), as of Dec 24, the value is 14.50. This value exceeds the healthy maximum of 3. It has increased from 12.75 (Dec 23) to 14.50, marking an increase of 1.75.
- For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 920.48. It has increased from 789.72 (Dec 23) to 920.48, marking an increase of 130.76.
- For PBDIT / Share (Rs.), as of Dec 24, the value is 195.01. This value is within the healthy range. It has increased from 158.50 (Dec 23) to 195.01, marking an increase of 36.51.
- For PBIT / Share (Rs.), as of Dec 24, the value is 172.42. This value is within the healthy range. It has increased from 140.80 (Dec 23) to 172.42, marking an increase of 31.62.
- For PBT / Share (Rs.), as of Dec 24, the value is 171.84. This value is within the healthy range. It has increased from 140.59 (Dec 23) to 171.84, marking an increase of 31.25.
- For Net Profit / Share (Rs.), as of Dec 24, the value is 130.31. This value is within the healthy range. It has increased from 104.90 (Dec 23) to 130.31, marking an increase of 25.41.
- For PBDIT Margin (%), as of Dec 24, the value is 21.18. This value is within the healthy range. It has increased from 20.07 (Dec 23) to 21.18, marking an increase of 1.11.
- For PBIT Margin (%), as of Dec 24, the value is 18.73. This value is within the healthy range. It has increased from 17.82 (Dec 23) to 18.73, marking an increase of 0.91.
- For PBT Margin (%), as of Dec 24, the value is 18.66. This value is within the healthy range. It has increased from 17.80 (Dec 23) to 18.66, marking an increase of 0.86.
- For Net Profit Margin (%), as of Dec 24, the value is 14.15. This value exceeds the healthy maximum of 10. It has increased from 13.28 (Dec 23) to 14.15, marking an increase of 0.87.
- For Return on Networth / Equity (%), as of Dec 24, the value is 18.48. This value is within the healthy range. It has increased from 17.84 (Dec 23) to 18.48, marking an increase of 0.64.
- For Return on Capital Employeed (%), as of Dec 24, the value is 23.79. This value is within the healthy range. It has increased from 23.22 (Dec 23) to 23.79, marking an increase of 0.57.
- For Return On Assets (%), as of Dec 24, the value is 14.32. This value is within the healthy range. It has increased from 13.40 (Dec 23) to 14.32, marking an increase of 0.92.
- For Asset Turnover Ratio (%), as of Dec 24, the value is 1.09. It has decreased from 1.10 (Dec 23) to 1.09, marking a decrease of 0.01.
- For Current Ratio (X), as of Dec 24, the value is 3.12. This value exceeds the healthy maximum of 3. It has increased from 3.10 (Dec 23) to 3.12, marking an increase of 0.02.
- For Quick Ratio (X), as of Dec 24, the value is 2.47. This value exceeds the healthy maximum of 2. It has increased from 2.38 (Dec 23) to 2.47, marking an increase of 0.09.
- For Inventory Turnover Ratio (X), as of Dec 24, the value is 2.59. This value is below the healthy minimum of 4. It has decreased from 2.64 (Dec 23) to 2.59, marking a decrease of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Dec 24, the value is 9.78. This value is below the healthy minimum of 20. It has increased from 7.86 (Dec 23) to 9.78, marking an increase of 1.92.
- For Dividend Payout Ratio (CP) (%), as of Dec 24, the value is 8.33. This value is below the healthy minimum of 20. It has increased from 6.72 (Dec 23) to 8.33, marking an increase of 1.61.
- For Earning Retention Ratio (%), as of Dec 24, the value is 90.22. This value exceeds the healthy maximum of 70. It has decreased from 92.14 (Dec 23) to 90.22, marking a decrease of 1.92.
- For Cash Earning Retention Ratio (%), as of Dec 24, the value is 91.67. This value exceeds the healthy maximum of 70. It has decreased from 93.28 (Dec 23) to 91.67, marking a decrease of 1.61.
- For Interest Coverage Ratio (X), as of Dec 24, the value is 335.48. This value is within the healthy range. It has decreased from 748.26 (Dec 23) to 335.48, marking a decrease of 412.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 225.17. This value is within the healthy range. It has decreased from 496.21 (Dec 23) to 225.17, marking a decrease of 271.04.
- For Enterprise Value (Cr.), as of Dec 24, the value is 8,763.00. It has increased from 6,817.43 (Dec 23) to 8,763.00, marking an increase of 1,945.57.
- For EV / Net Operating Revenue (X), as of Dec 24, the value is 4.69. This value exceeds the healthy maximum of 3. It has increased from 4.25 (Dec 23) to 4.69, marking an increase of 0.44.
- For EV / EBITDA (X), as of Dec 24, the value is 22.14. This value exceeds the healthy maximum of 15. It has increased from 21.19 (Dec 23) to 22.14, marking an increase of 0.95.
- For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 4.95. This value exceeds the healthy maximum of 3. It has increased from 4.54 (Dec 23) to 4.95, marking an increase of 0.41.
- For Retention Ratios (%), as of Dec 24, the value is 90.21. This value exceeds the healthy maximum of 70. It has decreased from 92.13 (Dec 23) to 90.21, marking a decrease of 1.92.
- For Price / BV (X), as of Dec 24, the value is 6.46. This value exceeds the healthy maximum of 3. It has increased from 6.10 (Dec 23) to 6.46, marking an increase of 0.36.
- For Price / Net Operating Revenue (X), as of Dec 24, the value is 4.95. This value exceeds the healthy maximum of 3. It has increased from 4.54 (Dec 23) to 4.95, marking an increase of 0.41.
- For EarningsYield, as of Dec 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Dec 23) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vesuvius India Ltd:
- Net Profit Margin: 14.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.79% (Industry Average ROCE: 18.1%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.48% (Industry Average ROE: 13.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 225.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.47
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 41.1 (Industry average Stock P/E: 38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Refractories | P-104, Taratala Road, Kolkata West Bengal 700088 | vesuviusindia@vesuvius.com http://www.vesuviusindia.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Biswadip Gupta | Chairperson |
| Mr. Mohinder Rajput | Managing Director |
| Mr. Sudipto Sarkar | Director |
| Mr. Pascal Genest | Director |
| Ms. Nayantara Palchoudhuri | Director |
| Mr. Patrick Andre | Director |
| Mr. Henry Knowles | Director |
| Mr. Nitin Jain | Director |
| Mr. Sunil Kumar Chaturvedi | Director |